Yosef Yarden

47.4k total citations · 19 hit papers
262 papers, 37.4k citations indexed

About

Yosef Yarden is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Yosef Yarden has authored 262 papers receiving a total of 37.4k indexed citations (citations by other indexed papers that have themselves been cited), including 177 papers in Molecular Biology, 155 papers in Oncology and 108 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Yosef Yarden's work include HER2/EGFR in Cancer Research (125 papers), Monoclonal and Polyclonal Antibodies Research (108 papers) and Glycosylation and Glycoproteins Research (56 papers). Yosef Yarden is often cited by papers focused on HER2/EGFR in Cancer Research (125 papers), Monoclonal and Polyclonal Antibodies Research (108 papers) and Glycosylation and Glycoproteins Research (56 papers). Yosef Yarden collaborates with scholars based in Israel, United States and Germany. Yosef Yarden's co-authors include Joseph Schlessinger, Ami Citri, Hadassa Waterman, Iris Alroy, Michael Sela, Sara Lavi, Gil Levkowitz, Gur Pines, A. Ullrich and Yaron Mosesson and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Yosef Yarden

258 papers receiving 36.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

1984 2.3k citations Yosef Yarden et al. profile →
EGF–ERBB signalling: towards the systems level

2006 1.6k citations Yosef Yarden et al. profile →
Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand.

1987 1.4k citations Yosef Yarden et al. The EMBO Journal profile →
The EGFR family and its ligands in human cancer

2001 1.3k citations Yosef Yarden profile →
Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors

1986 1.1k citations Yosef Yarden et al. profile →
A Hierarchical Network of Interreceptor Interactions Determines Signal Transduction by Neu Differentiation Factor/Neuregulin and Epidermal Growth Factor

1996 831 citations Eldad Tzahar, Gil Levkowitz et al. Molecular and Cellular Biology profile →
Ubiquitin Ligase Activity and Tyrosine Phosphorylation Underlie Suppression of Growth Factor Signaling by c-Cbl/Sli-1

1999 823 citations Gil Levkowitz, Iris Alroy et al. profile →
The ERBB network: at last, cancer therapy meets systems biology

2012 724 citations Yosef Yarden et al. profile →
c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor

1998 714 citations Gil Levkowitz, Yosef Yarden et al. profile →
Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions.

1996 645 citations Ronit Pinkas‐Kramarski, Lior Soussan et al. The EMBO Journal profile →
The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand‐receptor interactions

1997 608 citations Iris Alroy, Yosef Yarden profile →
Derailed endocytosis: an emerging feature of cancer

2008 557 citations Yosef Yarden et al. profile →
ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer.

1996 547 citations Eldad Tzahar, Roger R. Beerli et al. The EMBO Journal profile →
Circular RNAs are long-lived and display only minimal early alterations in response to a growth factor

2015 535 citations Mattia Lauriola, Yosef Yarden et al. profile →
Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor

1987 508 citations Yosef Yarden et al. profile →
Neu differentiation factor: A transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit

1992 504 citations Elior Peles, Sarah Bacus et al. profile →
Feedback regulation of EGFR signalling: decision making by early and delayed loops

2011 500 citations Yosef Yarden et al. profile →
EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance

2021 350 citations Mary Luz Uribe, Ilaria Marrocco et al. profile →
CircRNAs: role in human diseases and potential use as biomarkers

2021 270 citations Sabrina Strano, Yosef Yarden et al. profile →

Peers

Countries citing papers authored by Yosef Yarden

Since Specialization

Citations

This map shows the geographic impact of Yosef Yarden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yosef Yarden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yosef Yarden more than expected).

Fields of papers citing papers by Yosef Yarden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yosef Yarden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yosef Yarden. The network helps show where Yosef Yarden may publish in the future.

Co-authorship network of co-authors of Yosef Yarden

This figure shows the co-authorship network connecting the top 25 collaborators of Yosef Yarden. A scholar is included among the top collaborators of Yosef Yarden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yosef Yarden. Yosef Yarden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tuft cells and fibroblasts promote thymus regeneration through ILC2-mediated type 2 immune response 2024 ·Science Immunology ·Shir Nevo, N Frenkeĺ, Noam Kadouri, (unknown), (unknown), (unknown), (unknown), (unknown), Merav Kedmi, Moshit Lindzen, Shifra Ben‐Dor, (unknown), Ziv Porat, Rebecca Haffner‐Krausz, Hadas Keren‐Shaul, Yosef Yarden, Ariel Munitz, Dena Leshkowitz, Yael Goldfarb, Jakub Abramson	22
2	Computational optimization of antibody humanness and stability by systematic energy-based ranking 2023 ·Nature Biomedical Engineering ·(unknown), (unknown), (unknown), (unknown), Ashish Noronha, Moshit Lindzen, Emily K. Makowski, (unknown), (unknown), (unknown), Peter M. Tessier, Jakub Abramson, Yosef Yarden, Deborah Fass, Sarel J. Fleishman	19
3	Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive axis 2022 ·Nature Communications ·Yael Aylon, Noa Furth, Giuseppe Mallel, Gilgi Friedlander, Nishanth Belugali Nataraj, Meng Dong, Ori Hassin, (unknown), Benjamin Cohen, Vanessa Drendel, Tomer Meir Salame, Saptaparna Mukherjee, Nofar Harpaz, Randy L. Johnson, Walter E. Aulitzky, Yosef Yarden, Efrat Shema, Moshe Oren	5
4	Host-Dependent Phenotypic Resistance to EGFR Tyrosine Kinase Inhibitors 2021 ·Cancer Research ·(unknown), Ilaria Marrocco, Ashish Noronha, Mary Luz Uribe, Nishanth Belugali Nataraj, (unknown), Diana Drago-García, Simone Borgoni, Moshit Lindzen, (unknown), Stefan Wiemann, Yasuo Tsutsumi, Yosef Yarden	6
5	TP53 missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironment 2021 ·Proceedings of the National Academy of Sciences ·(unknown), Giuseppe Mallel, Nishanth Belugali Nataraj, Michal Shreberk‐Shaked, Ori Hassin, Saptaparna Mukherjee, Sharathchandra Arandkar, Ron Rotkopf, (unknown), (unknown), (unknown), (unknown), Ofra Golani, Yoseph Addadi, Emma Hajaj, Raya Eilam, Ravid Straussman, Yosef Yarden, Michal Lotem, Moshe Oren	72
6	Tumor Cell Invasion Can Be Blocked by Modulators of Collagen Fibril Alignment That Control Assembly of the Extracellular Matrix 2016 ·Cancer Research ·Moran Grossman, Nir Ben‐Chetrit, Alina Zhuravlev, Ran Afik, Elad Bassat, Inna Solomonov, Yosef Yarden, Irit Sagi	102
7	Examination of HER3 targeting in cancer using monoclonal antibodies 2015 ·Proceedings of the National Academy of Sciences ·Nadège Gaborit, Ali Abdul‐Hai, Maicol Mancini, Moshit Lindzen, Sara Lavi, Orith Leitner, (unknown), (unknown), (unknown), (unknown), Christel Larbouret, Thierry Chardès, Hervé Bazin, André Pèlegrin, Michael Sela, Yosef Yarden	35
8	Downregulation of microRNAs 145-3p and 145-5p Is a Long-term Predictor of Postmenopausal Breast Cancer Risk: The ORDET Prospective Study 2014 ·Cancer Epidemiology Biomarkers & Prevention ·Paola Muti, Andrea Sacconi, Ahmed Hossain, Sara Donzelli, Noa Bossel Ben‐Moshe, Federica Ganci, Sabina Sieri, Vittorio Krogh, Franco Berrino, Francesca Biagioni, Sabrina Strano, Joseph Beyene, Yosef Yarden, Giovanni Blandino	20
9	A recombinant decoy comprising EGFR and ErbB-4 inhibits tumor growth and metastasis 2011 ·Oncogene ·Moshit Lindzen, Sílvia Carvalho, Alex Starr, Nir Ben‐Chetrit, (unknown), Wolfgang J. Köstler, A. Rabinkov, Sara Lavi, Sarah Bacus, Yosef Yarden	25
10	Modeling ductal carcinoma in situ: a HER2–Notch3 collaboration enables luminal filling 2011 ·Oncogene ·(unknown), Wolfgang J. Köstler, Mattia Lauriola, Roy Z. Granit, (unknown), Jasmin Jacob–Hirsch, Gidi Rechavi, Hareesh B. Nair, Bryan T. Hennessy, Ana M. González-Angulo, Rajeshwar R. Tekmal, Ittai Ben‐Porath, G.B. Mills, Eytan Domany, Yosef Yarden	39
11	Biochemical and Clinical Implications of the ErbB/HER Signaling Network of Growth Factor Receptors 1999 ·Advances in cancer research ·Leah N. Klapper, Mark Kirschbaum, (unknown), Yosef Yarden	460
12	The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin 1998 ·Oncogene ·Ronit Pinkas‐Kramarski, Anne E.G. Lenferink, Sarah Bacus, Ljuba Lyass, (unknown), Leah N. Klapper, Eldad Tzahar, Michael Sela, (unknown), Yosef Yarden	75
13	Type 1 receptor tyrosine kinases are differentially phosphorylated in mammary carcinoma and differentially associated with steroid receptors. 1996 ·PubMed ·Sarah Bacus, D Chin, Yosef Yarden, C R Zelnick, David F. Stern	77
14	Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. breakdown → 1996 ·The EMBO Journal ·Ronit Pinkas‐Kramarski, Lior Soussan, Hayley R. Waterman, Gil Levkowitz, Iris Alroy, Leah N. Klapper, Sara Lavi, Rony Seger, Barry Ratzkin, Michael Sela, Yosef Yarden	645
15	Neu Differentiation Factor Activation of ErbB-3 and ErbB-4 Is Cell Specific and Displays a Differential Requirement for ErbB-2 1995 ·Molecular and Cellular Biology ·Roger R. Beerli, Diana Graus-Porta, K Woods-Cook, Xiaomei Chen, Yosef Yarden, Nancy E. Hynes	152
16	Suppression and promotion of tumor growth by monoclonal antibodies to ErbB-2 differentially correlate with cellular uptake. 1995 ·Proceedings of the National Academy of Sciences ·Esther Hurwitz, Ilana Stancovski, Michael Sela, Yosef Yarden	132
17	Neu Differentiation Factors: A Family of Alternatively Spliced Neuronal and Mesenchymal Factors 1994 ·Experimental Biology and Medicine ·Noa Ben-Baruch, Yosef Yarden	56
18	Medullary carcinoma is associated with expression of intercellular adhesion molecule-1. Implication to its morphology and its clinical behavior. 1994 ·PubMed ·S S Bacus, C R Zelnick, D Chin, Yosef Yarden, David Kaminsky, James L. Bennington, D Wen, Joseph Marcus, David L. Page	25
19	Cell-type specific interaction of Neu differentiation factor (NDF/heregulin) with Neu/HER-2 suggests complex ligand-receptor relationships. 1993 ·The EMBO Journal ·Elior Peles, R Ben-Levy, Eldad Tzahar, (unknown), D Wen, Yosef Yarden	204
20	Targeting of T lymphocytes to Neu/HER2-expressing cells using chimeric single chain Fv receptors. 1993 ·The Journal of Immunology ·Ilana Stancovski, Daniel Schindler, Tova Waks, Yosef Yarden, Michael Sela, Zelig Eshhar	169

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact